Prognostic impact of cardiohepatic syndrome in patients with ST-segment elevation myocardial infarction

被引：0
|
作者：
Sungur, Mustafa A. [1 ]
Sungur, Aylin [2 ]
Karagoz, Ali [3 ]
Can, Fatma [1 ]
Yilmaz, Mehmet F. [1 ]
Zeren, Gonul [1 ]
Avci, Ilhan I. [1 ]
Yumurtas, Ahmet C. [1 ]
Tanboga, Ibrahim H. [4 ]
Karabay, Can Y. [1 ]
机构：
[1] Dr Siyami Ersek Thorac & Cardiovasc Surg Educ Res, Dept Cardiol, Selimiye Mh Tibbiye Cd 25,Uskudar, Istanbul, Turkiye
[2] Sureyyapasa Chest Dis & Thorac Surg Training & Re, Dept Cardiol, Basibuyuk Mh Sureyyapasa Yerleskesi, Istanbul, Turkiye
[3] Kartal Kosuyolu Heart Training & Res Hosp, Dept Cardiol, Denizer Cd Cevizli Kavsagi 2 Kartal, Istanbul, Turkiye
[4] Nisantasi Univ, Dept Cardiol, Saray Mh Site Yolu Cd 7 Umraniye, Istanbul, Turkiye
来源：
BIOMARKERS IN MEDICINE | 2023年 / 17卷 / 02期
关键词：
cardiohepatic syndrome; in-hospital mortality; long-term mortality; ST-segment elevation myocardial infarction; GAMMA-GLUTAMYL-TRANSFERASE; SERUM ALKALINE-PHOSPHATASE; IN-HOSPITAL MACE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; MORTALITY; RISK; GUIDELINES; PREDICTOR; BILIRUBIN;
D O I：
10.2217/bmm-2022-0770
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Background: Cardiohepatic syndrome (CHS) indicates a bidirectional interaction between the heart and liver. This study was designed to evaluate the impact of CHS on in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention. Materials & methods: 1541 consecutive STEMI patients were examined. CHS was defined as the elevation of at least two of three cholestatic liver enzymes: total bilirubin, alkaline phosphatase and gamma-glutamyl transferase. Results: CHS was present in 144 (9.34%) patients. Multivariate analyses revealed CHS as an independent predictor of in-hospital (odds ratio: 2.48; 95% CI: 1.42-4.34; p = 0.001) and long-term mortality (hazard ratio: 2.4; 95% CI: 1.79-3.22; p < 0.001). Conclusion: The presence of CHS is a predictor of poor prognosis in patients with STEMI and should be evaluated during the risk stratification of these patients.
引用
收藏
页码：111 / 121
页数：11
相关论文
共 50 条
  • [31] Infarct characteristics and outcome of patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarction
    Demirkiran, A.
    Hoeven, N.
    Janssens, G.
    Lemkes, J.
    Everaars, H.
    Ven, P.
    Cauteren, Y.
    Leeuwen, M.
    Nap, A.
    Bekkers, S.
    Royen, N.
    Smulders, M.
    Rossum, A.
    Robbers, L.
    Nijveldt, R.
    EUROPEAN HEART JOURNAL, 2020, 41 : 195 - 195
  • [32] The Systemic Inflammatory Response Syndrome in Patients With ST-Segment Elevation Myocardial Infarction
    van Diepen, Sean
    Vavalle, John P.
    Newby, L. Kristin
    Clare, Robert
    Pieper, Karen S.
    Ezekowitz, Justin A.
    Hochman, Judith S.
    Mahaffey, Kenneth W.
    Armstrong, Paul W.
    Granger, Christopher B.
    CRITICAL CARE MEDICINE, 2013, 41 (09) : 2080 - 2087
  • [33] Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction
    Rikuta Hamaya
    Yoshihisa Kanaji
    Masahiro Hada
    Yoshinori Kanno
    Eisuke Usui
    Masahiro Hoshino
    Masao Yamaguchi
    Yohei Sumino
    Tomoki Horie
    Hidenori Hirano
    Tomoyo Sugiyama
    Tsunekazu Kakuta
    Heart and Vessels, 2020, 35 : 936 - 945
  • [34] Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction
    Hamaya, Rikuta
    Kanaji, Yoshihisa
    Hada, Masahiro
    Kanno, Yoshinori
    Usui, Eisuke
    Hoshino, Masahiro
    Yamaguchi, Masao
    Sumino, Yohei
    Horie, Tomoki
    Hirano, Hidenori
    Sugiyama, Tomoyo
    Kakuta, Tsunekazu
    HEART AND VESSELS, 2020, 35 (07) : 936 - 945
  • [35] Clinical impact of thrombus burden in patients with ST-segment elevation myocardial infarction
    Kume, Teruyoshi
    Uemura, Shiro
    CORONARY ARTERY DISEASE, 2016, 27 (03) : 165 - 166
  • [36] INFARCT CHARACTERISTICS, TREATMENT, AND CLINICAL OUTCOME IN PATIENTS WITH TRANSIENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION VERSUS ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS
    Janssens, Gladys
    van der Hoeven, Nina
    Lemkes, Jorrit
    Van Leeuwen, Maarten
    de Ven, Peter van
    Brinckman, Stijn
    Timmer, Jorik
    Meuwissen, Martijn
    Van der Weerdt, Arno
    Ten Cate, Tim
    Piek, Jan
    von Birgelen, Clemens
    Diletti, Roberto
    Escaned, Javier
    van Rossum, Albert
    Nijveldt, Robin
    Van Royen, Niels
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 278 - 278
  • [37] Prognostic value of angiographic microvascular resistance in patients with ST-segment elevation myocardial infarction
    Qian, Gangzhen
    Qin, Haoran
    Deng, Dan
    Feng, Yue
    Zhang, Chao
    Qu, Xiaolong
    Zhang, Zhihui
    CLINICS, 2024, 79
  • [38] IMPACT OF THE CLINICAL FRAILTY SCALE ON ADVERSE EVENTS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IMPACT OF THE CLINICAL FRAILTY SCALE ON ADVERSE EVENTS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
    Kurobe, Masanari
    Uchida, Yasuhiro
    Yonekawa, Jun
    Makino, Yuichiro
    Satake, Akinori
    Suzuki, Wataru
    Mizutani, Koji
    Mizutani, Yoshiaki
    Ichimiya, Hitoshi
    Watanabe, Junji
    Kanashiro, Masaaki
    Ichimiya, Satoshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1080 - 1080
  • [39] The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarction
    Bates, Eric R.
    AMERICAN HEART JOURNAL, 2010, 160 (04) : 574 - 576
  • [40] The Prognostic Value of Peripheral Artery Diseases in Patients with ST-Segment Elevation Myocardial Infarction
    Barbarash, Olga L.
    Zykov, Mikhail V.
    Pecherina, Tamara B.
    Kashtalap, Vasily V.
    Barbarash, Leonid S.
    Kutikhin, Anton G.
    DISEASE MARKERS, 2013, 2013 : 877 - 882
12345